We are live on
!
Find out more
N
Natixis Portfolio holdings
AUM
$28B
1-Year Est. Return
26.79%
Natixis is a global financial services business line of Groupe BPCE, offering a range of services including corporate and investment banking, asset management, insurance, and wealth management, with a focus on green and sustainable finance.
This Fund
S&P 500
This Quarter
Est. Return
-2.18%
1 Year Est. Return
+26.79%
3 Year Est. Return
+97.72%
5 Year Est. Return
+108.83%
10 Year Est. Return
+452.99%
AUM
$13.1B
AUM Growth
+$754M
(+6.1%)
Cap. Flow
+$1.16B
Cap. Flow
% of AUM
8.89%
Top 10 Holdings %
Top 10 Hldgs %
38.02%
Holding
1,188
New
182
Increased
340
Reduced
340
Closed
221
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$379M |
| 2 |
NVIDIA
NVDA
|
+$323M |
| 3 |
Amazon
AMZN
|
+$133M |
| 4 |
UnitedHealth
UNH
|
+$97.5M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$86.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$89.2M |
| 2 |
ExxonMobil
XOM
|
+$83.6M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$83.1M |
| 4 |
CVS Health
CVS
|
+$82.2M |
| 5 |
Eli Lilly
LLY
|
+$66.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.23% |
| 2 | Healthcare | 11.42% |
| 3 | Energy | 7.9% |
| 4 | Consumer Discretionary | 6.67% |
| 5 | Financials | 5.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.9B
| $1.37M | 0.01% |
77,013
-1,620
| -2% | -$30.2K |
|
452
Cardinal Health
CAH
$53.4B
| $1.37M | 0.01% |
15,730
-16,621
| -51% | -$1.5M |
|
453
Snowflake
SNOW
$92.9B
| $1.36M | 0.01% |
8,890
-1,743
| -16% | -$284K |
|
454
Hess Midstream
HESM
$5.22B
| $1.31M | 0.01% |
45,000
| – | – |
|
455
Iron Mountain
IRM
$38.2B
| $1.31M | 0.01% |
22,047
-35,530
| -62% | -$2.17M |
|
456
Invesco Large Cap Value ETF
PWV
$1.66B
| $1.3M | 0.01% |
27,835
-2,024
| -7% | -$96.6K |
|
457
Hyatt Hotels
H
$17.6B
| $1.29M | 0.01% |
+12,184
| New | +$1.39M |
|
458
Schneider National
SNDR
$6.59B
| $1.29M | 0.01% |
+46,500
| New | +$1.35M |
|
|
CPRX
459
DELISTED
Catalyst Pharmaceutical
CPRX
| $1.27M | 0.01% |
+108,300
| New | +$1.45M |
|
460
Samsara
IOT
$19.3B
| $1.27M | 0.01% |
+50,200
| New | +$1.33M |
|
461
Sun Communities
SUI
$15B
| $1.25M | 0.01% |
10,554
-21,376
| -67% | -$2.71M |
|
462
Rapid7
RPD
$634M
| $1.25M | 0.01% |
27,276
-273,756
| -91% | -$12.6M |
|
463
Workiva
WK
$2.94B
| $1.22M | 0.01% |
12,026
-2,300
| -16% | -$239K |
|
464
Targa Resources
TRGP
$60.4B
| $1.21M | 0.01% |
14,158
+430
| +3% | +$35.6K |
|
465
Molina Healthcare
MOH
$10.3B
| $1.21M | 0.01% |
3,693
-71,997
| -95% | -$22.7M |
|
|
AXNX
466
DELISTED
Axonics, Inc. Common Stock
AXNX
| $1.21M | 0.01% |
21,518
-3,420
| -14% | -$192K |
|
467
Healthpeak Properties
DOC
$15.4B
| $1.21M | 0.01% |
65,723
+1,460
| +2% | +$30K |
|
468
Lattice Semiconductor
LSCC
$17.6B
| $1.2M | 0.01% |
13,922
-14,500
| -51% | -$1.31M |
|
|
IMGN
469
DELISTED
Immunogen Inc
IMGN
| $1.19M | 0.01% |
+75,000
| New | +$1.25M |
|
470
Strategy Inc
MSTR
$33.5B
| $1.18M | 0.01% |
35,970
+15,980
| +80% | +$602K |
|
471
VeriSign
VRSN
$25.3B
| $1.18M | 0.01% |
5,830
-7,903
| -58% | -$1.64M |
|
472
Ultragenyx Pharmaceutical
RARE
$2.65B
| $1.18M | 0.01% |
33,100
-31,600
| -49% | -$1.25M |
|
473
First Citizens BancShares
FCNCA
$24.6B
| $1.15M | 0.01% |
835
-1,894
| -69% | -$2.6M |
|
|
DFS
474
DELISTED
Discover Financial Services
DFS
| $1.15M | 0.01% |
+13,262
| New | +$1.32M |
|
475
OneMain Financial
OMF
$6.9B
| $1.15M | 0.01% |
+28,600
| New | +$1.22M |
|
Similar funds
TWC
FDCDDQ
PCH
NA
Natixis's Q3 2023 Portfolio in Review
As of Q3 2023, Natixis held 1,188 positions worth $13.1B, up 6.1% from $12.3B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Natixis deployed $1.16B of net new capital in Q3 2023, opening 182 new positions and adding to 340 existing holdings. Its largest new stake was Oneok: 965,015 shares worth $61.2M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 21% a quarter earlier, followed by Healthcare and Energy.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $89.2M trimmed.
- Natixis's largest Q3 2023 buy was Oneok: 965,015 shares worth $61.2M.
- Natixis added most to Apple in Q3 2023, an estimated $379M increase.
- Natixis's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $89.2M.
- Natixis fully exited Bristol-Myers Squibb in Q3 2023, selling an estimated $83.1M.
- Natixis's ten largest holdings make up 38% of its $13.1B portfolio in Q3 2023.
- Natixis opened 182 new positions and closed 221 in Q3 2023.
- Natixis's portfolio value rose 6.1% quarter-over-quarter to $13.1B.
Based on Natixis's 13F filing for Q3 2023, filed 14 Nov 2023.